Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2942588498;88499;88500 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
N2AB2778483575;83576;83577 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
N2A2685780794;80795;80796 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
N2B2036061303;61304;61305 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
Novex-12048561678;61679;61680 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
Novex-22055261879;61880;61881 chr2:178556881;178556880;178556879chr2:179421608;179421607;179421606
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Fn3-102
  • Domain position: 91
  • Structural Position: 123
  • Q(SASA): 0.1617
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/D None None 0.177 N 0.705 0.154 0.275215494804 gnomAD-4.0.0 3.18286E-06 None None None None N None 0 0 None 0 0 None 0 0 5.71602E-06 0 0
V/F rs1701721466 None 0.177 N 0.758 0.03 0.235038932564 gnomAD-4.0.0 2.73695E-06 None None None None N None 0 0 None 0 0 None 0 0 0 4.63736E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.0809 likely_benign 0.0869 benign -1.086 Destabilizing None N 0.209 neutral N 0.421690468 None None N
V/C 0.5729 likely_pathogenic 0.5717 pathogenic -0.719 Destabilizing 0.685 D 0.644 neutral None None None None N
V/D 0.2399 likely_benign 0.2186 benign -0.518 Destabilizing 0.177 N 0.705 prob.delet. N 0.507117297 None None N
V/E 0.2364 likely_benign 0.2135 benign -0.505 Destabilizing 0.039 N 0.644 neutral None None None None N
V/F 0.1884 likely_benign 0.1555 benign -0.72 Destabilizing 0.177 N 0.758 deleterious N 0.493206637 None None N
V/G 0.1623 likely_benign 0.1595 benign -1.389 Destabilizing 0.03 N 0.637 neutral N 0.507117297 None None N
V/H 0.4544 ambiguous 0.4222 ambiguous -0.73 Destabilizing 0.685 D 0.645 neutral None None None None N
V/I 0.0765 likely_benign 0.0694 benign -0.366 Destabilizing None N 0.169 neutral N 0.401757913 None None N
V/K 0.2853 likely_benign 0.2637 benign -0.799 Destabilizing 0.039 N 0.643 neutral None None None None N
V/L 0.174 likely_benign 0.1477 benign -0.366 Destabilizing None N 0.211 neutral N 0.429136516 None None N
V/M 0.1255 likely_benign 0.1167 benign -0.391 Destabilizing 0.221 N 0.585 neutral None None None None N
V/N 0.1697 likely_benign 0.1583 benign -0.683 Destabilizing 0.125 N 0.705 prob.delet. None None None None N
V/P 0.1741 likely_benign 0.1751 benign -0.57 Destabilizing 0.221 N 0.68 prob.neutral None None None None N
V/Q 0.2818 likely_benign 0.2674 benign -0.789 Destabilizing 0.221 N 0.654 prob.neutral None None None None N
V/R 0.2721 likely_benign 0.241 benign -0.343 Destabilizing 0.221 N 0.699 prob.delet. None None None None N
V/S 0.1227 likely_benign 0.1243 benign -1.239 Destabilizing None N 0.638 neutral None None None None N
V/T 0.0914 likely_benign 0.0935 benign -1.106 Destabilizing 0.001 N 0.261 neutral None None None None N
V/W 0.7412 likely_pathogenic 0.6993 pathogenic -0.889 Destabilizing 0.869 D 0.682 prob.neutral None None None None N
V/Y 0.4508 ambiguous 0.4106 ambiguous -0.572 Destabilizing 0.366 N 0.723 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.